API
< Back to all clusters
[HEALTH] · India · 6 sources

started · updated

India proposes 30% trade margin cap on cancer drugs

The Indian government has filed an affidavit with the Supreme Court acknowledging that hospitals often charge excessive mark-ups on medicines and medical supplies. According to the government, some cancer drugs face mark-ups ranging from 170% to over 700%, while medical consumables can see margins between 100% and 1,000%.

To address this, the Department of Pharmaceuticals has proposed capping trade margins on non-scheduled cancer drugs at 30% of the Maximum Retail Price (MRP). This measure is estimated to reduce drug prices by 20% to 70%, potentially saving patients approximately ₹2,500 crore annually.

The Ministry of Health and Family Welfare has constituted an expert committee, chaired by the Director General of Health Services, to identify specific medications subject to these regulations. The committee is expected to submit its report within 10 to 15 days. Following this, the National Pharmaceutical Pricing Authority (NPPA) will review the findings and issue necessary price notifications.

Entities

Department of Pharmaceuticals · India · Ministry of Health and Family Welfare · National Pharmaceutical Pricing Authority · Supreme Court of India

Claims

What the coverage asserts, and how many sources carry each claim.